期刊
NATURE BIOTECHNOLOGY
卷 40, 期 3, 页码 291-295出版社
NATURE PORTFOLIO
DOI: 10.1038/s41587-022-01246-w
关键词
-
Protective encapsulating devices and gene-editing technologies may eliminate the need for antirejection drugs in stem-cell-derived therapies for diabetes.
Protective encapsulating devices and gene-editing technologies could obviate the need for antirejection drugs in stem-cell-derived therapies for diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据